Nisha Davé

Parenteral glutamine supplementation in critical illness: a systematic review

Long‐term Administration of Rapamycin Reduces Adiposity, but Impairs Glucose Tolerance in High‐Fat Diet‐fed KK/HlJ Mice

mTOR Signaling in Growth Control and Disease

Calcineurin Inhibitor Nephrotoxicity

ESPEN guideline: Clinical nutrition in surgery

ESPEN guideline on clinical nutrition in the intensive care unit

Role of platelet-derived growth factors in physiology and medicine

EFFECTIVENESS AND COST-EFFECTIVENESS OF SUPPLEMENTAL GLUTAMINE DIPEPTIDE IN TOTAL PARENTERAL NUTRITION THERAPY FOR CRITICALLY ILL PATIENTS: A DISCRETE EVENT SIMULATION MODEL BASED ON ITALIAN DATA

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs

Rapamycin: One Drug, Many Effects

A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation

Severe Sepsis and Septic Shock

Perioperative Intravenous Glutamine Supplemetation in Major Abdominal Surgery for Cancer

Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics

The effect of l-alanyl-l-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients*

The Impact of Glutamine Dipeptide–Supplemented Parenteral Nutrition on Outcomes of Surgical Patients

Rapamycin Protects Against High Fat Diet–Induced Obesity in C57BL/6J Mice

Glutamine dipeptide-supplemented parenteral nutrition improves the clinical outcomes of critically ill patients: A systematic evaluation of randomised controlled trials

A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?

Early versus Late Parenteral Nutrition in Critically Ill Adults

Combined Effects of Losartan and Pravastatin on Interstitial Inflammation and Fibrosis in Chronic Cyclosporine-Induced Nephropathy

Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence

The use of antiviral agents for the management of severe influenza

Review of Phase II Trial Designs Used in Studies of Molecular Targeted Agents: Outcomes and Predictors of Success in Phase III

HMG CoA reductase inhibitors (statins) for kidney transplant recipients

Phase I and Pharmacokinetic Study of Imatinib Mesylate (Gleevec) and Gemcitabine in Patients with Refractory Solid Tumors

Effect of Glutamine Dipeptide Supplementation on Primary Outcomes for Elective Major Surgery: Systematic Review and Meta-Analysis

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Fish oil for kidney transplant recipients

A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancer

Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate

Efficacy of Parenteral Nutrition Supplemented With Glutamine Dipeptide to Decrease Hospital Infections in Critically Ill Surgical Patients

Clinical and Biological Activity of Soy Protein Powder Supplementation in Healthy Male Volunteers

Drug-related dyslipidemia after renal transplantation